相关实验视频

Updated: Jun 3, 2025

Author Spotlight: Investigating Immune Cell Dynamics in the Tumor Microenvironment — Challenges and Innovations in Cancer Prognosis

Author Spotlight: Investigating Immune Cell Dynamics in the Tumor Microenvironment — Challenges and Innovations in Cancer Prognosis

Published on: April 12, 2024

免疫微环境和血管内皮生长因子抑制在肝细胞癌的作用

Kyoko Oura¹, Asahiro Morishita¹, Tomoko Tadokoro¹

¹Department of Gastroenterology and Neurology, Faculty of Medicine, Kagawa University, 1750-1 Ikenobe, Miki, Kita 761-0793, Kagawa, Japan.

International journal of molecular sciences

|January 8, 2025

概括

血管内皮生长因子 (VEGF) 通过促进瘤生长和血管生成,在不可切除的肝细胞癌 (HCC) 中发挥关键作用. 向VEGF提供了一种双重方法来抑制癌症和调节免疫反应,以改善治疗策略.

科学领域:

在瘤学瘤学.
免疫学免疫学免疫学
血管新生研究研究

背景情况:

针对不可切除的肝细胞癌 (HCC) 的全身疗法已经通过向疗法和免疫检查点抑制剂取得了进展.
血管内皮生长因子 (VEGF) 信号传递对于HCC的癌症生长和血管生成至关重要.
目前的治疗方法包括多酶抑制剂和像阿特佐利祖马布+贝瓦西祖马布这样的免疫疗法.

研究的目的:

审查VEGF在瘤免疫微环境和HCC癌症免疫循环中的作用.
概述VEGF.的潜在免疫调节机制.
澄清最新的治疗策略,通过血管生成和免疫相关分子的双重抑制来最大限度地提高疗效.

主要方法:

对不可切除的HCC的全身疗法的文献综述.
分析VEGF在瘤免疫学和血管生成中的作用.
讨论针对VEGF的当前和新兴治疗策略.

主要成果:

抑制VEGF因其抗血管性作用和对癌症免疫循环的影响而得到认可.
阿特佐利祖马布 + 贝瓦齐祖马布治疗强调了结合免疫疗法与VEGF抑制的疗效.
在HCC中,VEGF影响瘤免疫微环境和癌症免疫循环.

结论:

在HCC的进展和瘤免疫微环境中,VEGF起着重要的作用.
针对血管新生和免疫路径的双重抑制策略显示出对不可切除的HCC的承诺.
了解VEGF的免疫调节机制是优化未来HCC治疗的关键.

关键词:

它们是Atezolizumab.这是bevacizumab的治疗方法.达尔瓦卢马布 (Durvalumab) 是一种耐用药.肝细胞癌是肝细胞癌.免疫检查点抑制剂免疫检查点抑制剂免疫周期的免疫循环.免疫微观环境免疫微环境监管性T细胞监管性T细胞这就是为什么特雷米利木马布.血管内皮生长因子血管内皮生长因子

更多相关视频

An Oncogenic Hepatocyte-Induced Orthotopic Mouse Model of Hepatocellular Cancer Arising in the Setting of Hepatic Inflammation and Fibrosis

An Oncogenic Hepatocyte-Induced Orthotopic Mouse Model of Hepatocellular Cancer Arising in the Setting of Hepatic Inflammation and Fibrosis

Published on: September 12, 2019

The In Ovo Chick Chorioallantoic Membrane CAM Assay as an Efficient Xenograft Model of Hepatocellular Carcinoma

The In Ovo Chick Chorioallantoic Membrane CAM Assay as an Efficient Xenograft Model of Hepatocellular Carcinoma

Published on: October 9, 2015

相关概念视频

Regulation of Angiogenesis and Blood Supply

Regulation of Angiogenesis and Blood Supply

Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits. Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl...

The Tumor Microenvironment

The Tumor Microenvironment

Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...